Thomas A. Marciniak

2.7k total citations
34 papers, 2.0k citations indexed

About

Thomas A. Marciniak is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Thomas A. Marciniak has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 13 papers in Economics and Econometrics and 5 papers in Surgery. Recurrent topics in Thomas A. Marciniak's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Acute Myocardial Infarction Research (10 papers) and Heart Failure Treatment and Management (9 papers). Thomas A. Marciniak is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Acute Myocardial Infarction Research (10 papers) and Heart Failure Treatment and Management (9 papers). Thomas A. Marciniak collaborates with scholars based in United States, South Korea and Canada. Thomas A. Marciniak's co-authors include Martha J. Radford, Jersey Chen, Harlan M. Krumholz, Harlan M. Krumholz, Yun Wang, Yun Wang, Edward F. Ellerbeck, Yun Wang, Timothy F. Kresowik and Stephen F. Jencks and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Thomas A. Marciniak

33 papers receiving 1.9k citations

Peers

Countries citing papers authored by Thomas A. Marciniak

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Marciniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Marciniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Marciniak more than expected).

Fields of papers citing papers by Thomas A. Marciniak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Marciniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Marciniak. The network helps show where Thomas A. Marciniak may publish in the future.

Co-authorship network of co-authors of Thomas A. Marciniak

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Marciniak. A scholar is included among the top collaborators of Thomas A. Marciniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Marciniak. Thomas A. Marciniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths 2023 ·PubMed ·Victor L. Serebruany, Jean‐François Tanguay, Héctor A. Cabrera-Fuentes, (unknown), Thomas A. Marciniak, (unknown)	2
2	Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial 2020 ·American Journal of Therapeutics ·Victor L. Serebruany, Jean‐François Tanguay, (unknown), Héctor A. Cabrera-Fuentes, Wolfgang G. Eisert, Moo Hyun Kim, Junghan Yoon, Cheol-Whan Lee, (unknown), James Swan, Thomas A. Marciniak	8
3	Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients? 2019 ·The American Journal of Medicine ·Thomas A. Marciniak, Dan Atar, Victor L. Serebruany	1
4	Filing Sources after Oral P<sub>2</sub>Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS) 2017 ·Cardiology ·Victor L. Serebruany, (unknown), (unknown), (unknown), Héctor A. Cabrera-Fuentes, Thomas A. Marciniak	1
5	Are drug regulators really too slow? 2017 ·BMJ ·Thomas A. Marciniak, Victor L. Serebruany	1
6	Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma 2001 ·Journal of the American College of Cardiology ·Jersey Chen, Martha J. Radford, Yun Wang, Thomas A. Marciniak, Harlan M. Krumholz	126
7	Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (The Cooperative Cardiovascular Project) 2001 ·The American Journal of Cardiology ·Alan K. Berger, Jeffrey A. Breall, Bernard J. Gersh, (unknown), William J. Oetgen, Thomas A. Marciniak, Kevin A. Schulman	36
8	Are β-Blockers Effective in Elderly Patients Who Undergo Coronary Revascularization After Acute Myocardial Infarction? 2000 ·Archives of Internal Medicine ·Jersey Chen, Martha J. Radford, Yun Wang, Thomas A. Marciniak, Harlan M. Krumholz	49
9	Impact of quality improvement activities on care for acute myocardial infarction 2000 ·International Journal for Quality in Health Care ·Edward F. Ellerbeck, Timothy F. Kresowik, (unknown), P. Mason, R. Todd Wiblin, Thomas A. Marciniak	21
10	Improving the Quality of Care for Medicare Patients with Acute Myocardial Infarction: Results from the Cooperative Cardiovascular Project 1999 ·Survey of Anesthesiology ·Thomas A. Marciniak, Edward F. Ellerbeck, Martha J. Radford, Timothy F. Kresowik, Jay A Gold, Harlan M. Krumholz, Catarina I. Kiefe, Richard M. Allman, Robert A. Vogel, Stephen F. Jencks	56
11	Geographic Variation in the Treatment of Acute Myocardial Infarction 1999 ·JAMA ·(unknown), Hebe B. Quinton, Neal D. Traven, Lawrence D. Ramunno, (unknown), Thomas A. Marciniak, John E. Wennberg	257
12	Use of critical pathways to improve the care of patients with acute myocardial infarction 1999 ·The American Journal of Medicine ·Eric S. Holmboe, Thomas P. Meehan, Martha J. Radford, Yun Wang, Thomas A. Marciniak, Harlan M. Krumholz	36
13	Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? 1999 ·New England Journal of Medicine ·Jersey Chen, Martha J. Radford, Yun Wang, Thomas A. Marciniak, Harlan M. Krumholz	218
14	Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients 1999 ·Journal of the American College of Cardiology ·(unknown), Thomas A. Marciniak, Martha J. Radford, Yun Wang, Harlan M. Krumholz	68
15	Comparing AMI Mortality Among Hospitals in Patients 65 Years of Age and Older 1999 ·Circulation ·Harlan M. Krumholz, Jersey Chen, Yongfei Wang, Martha J. Radford, Yating Chen, Thomas A. Marciniak	135
16	Beta-blockers for the acute treatment of elderly patients with myocardial infarction: experience from the national cooperative cardiovascular project 1998 ·Journal of the American College of Cardiology ·(unknown), Martha J. Radford, (unknown), (unknown), Thomas A. Marciniak, Viola Vaccarino, (unknown)	1
17	National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction 1998 ·JAMA ·Harlan M. Krumholz, Martha J. Radford, Yun Wang, Jersey Chen, (unknown), Thomas A. Marciniak	393
18	Improving the Quality of Care for Medicare Patients With Acute Myocardial Infarction 1998 ·JAMA ·Thomas A. Marciniak, Edward F. Ellerbeck, Martha J. Radford, Timothy F. Kresowik, Jay A Gold, Harlan M. Krumholz, Catarina I. Kiefe, Richard M. Allman, Robert A. Vogel, Stephen F. Jencks	411
19	Resource use and quality of care for Medicare patients with acute myocardial infarction in Maryland and the District of Columbia: Analysis of data from the Cooperative Cardiovascular Project 1998 ·American Heart Journal ·Alan K. Berger, (unknown), Jeffrey A. Breall, William J. Oetgen, Thomas A. Marciniak, Gaetano F. Molinari	13
20	Accessing NCI's SEER cancer data base with SeerQuery and CD-ROM. 1992 ·PubMed ·Siddhartha Srivastava, (unknown), Thomas A. Marciniak, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact